RPB News

RPB-SUPPORTED RESEARCHERS WILL BE INTEGRAL PART OF LATEST EFFORT WITHIN NEI’S AUDACIOUS GOALS INITIATIVE

Vision scientists who have received RPB funding will help lead all five research teams, which will seek to accelerate development of regenerative treatments for blindness.

Feature Story

Grants

Top Story

EMERGING VISION SCIENTISTS EDUCATE, THANK CONGRESS FOR RESEARCH APPROPRIATIONS

(NAEVR) held its Fourth Annual Emerging Vision Scientists (EVS) Day on Capitol Hill and twenty early-stage investigators participated.

RESEARCH TO PREVENT BLINDNESS AND LIONS CLUBS INTERNATIONAL FOUNDATION TO CONTINUE LOW VISION RESEARCH AWARD PARTNERSHIP

Research to Prevent Blindness (RPB) and Lions Clubs International Foundation (LCIF) announced today that they will continue their partnership in the RPB/LCIF Low Vision Research Award.

Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research

IN THE FUTURE, ALZHEIMER’S MAY BE PREDICTED DURING EYE EXAMS

RPB-funded researchers at Washington University School of Medicine in St. Louis (WUSTL) have found a correlation in 30 older patients between retina thinning and elevated levels of tau and amyloid proteins that are the hallmark of Alzheimer’s disease.

Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2018 Recipient of RPB David F. Weeks Award for Outstanding AMD Research

RPB and AUPO announce 2018 recipient of David F. Weeks Award for outstanding AMD research.

Groundbreaking Gene Therapy for Retinal Disease

The first patient receives an FDA-approved gene therapy for inherited retinal disease at Mass. Eye and Ear.

RPB and AAO Award Grants for Big Data Research to Advance Patient Care

Award recipients to use IRIS Registry database to conduct population-based studies.

Research to Prevent Blindness Expands Grants Program

Many of the organization’s individual grants will now be open to researchers at any U.S. academic medical center.

Study Tests Stem Cell-based Therapy for Advanced Dry AMD

RPB-supported researchers at the University of Southern California Roski Eye Institute conducted the human trial.

Study Links Aging Immune Cells and AMD

RPB-supported researchers at Washington University School of Medicine in St. Louis published the new findings.

The National Eye Institute Turns 50

RPB celebrates five decades of sight-saving discoveries at NEI.

Vision Funders Collaborate for Impact

RPB hosted its fifth annual convening of organizations that fund vision research in Washington DC.

RPB and AAO Announce New Grant Opportunities to Support Vision Research

Partnership to utilize IRIS Registry database to advance patient care.

Reversing Retinal Degenerative Diseases: We’re One Step Closer

RPB-supported researchers made a critical discovery about the gene mutation that causes many retinal degenerative diseases, opening the door for a new line of research into potential treatments.

Understanding Usher Syndrome: New Findings

RPB-supported researchers make progress in characterizing the genetic components of Usher syndrome.

New Stem Cell Model Replicates Macular Degeneration

The model will allow researchers to better assess treatments for this hard-to-study cause of blindness.

Researchers ID Key Compounds Related to Blood Vessel Growth in Wet AMD

The findings may have significant therapeutic implications for AMD, the most common cause of elderly blindness in the developed world

RPB-supported Researchers ID Master Molecule behind Corneal Inflammation

RPB-supported researchers at the University of Illinois at Chicago have identified an enzyme present in the cornea that triggers inflammation during and even after a herpes virus infection.

Feature Story

Top Story

Electric Fields ‘Steer’ Neural Stem Cells

New RPB-supported research provides hope for transplants of neural stem cells as future treatment for brain injuries.

July is Dry Eye Awareness Month

Dry eye, a global problem affecting more than 30 million people in the U.S. alone, occurs when the eye does not produce tears properly or when the tears are not of the correct consistency and evaporate too quickly.

Researchers Identify Biomarker for Glaucoma Damage

The RPB-supported researchers hope their finding will lead to tests to identify cell damage before irreversible vision loss.

Working Together to Fund Scientific Research for Eye Health

More than 30 private and public funders of vision research came together in Washington DC to discuss ways to maximize their support of scientific research in light of new recommendations and a changing environment.